Inventor
David Klatzmann
Inventor
Paris, FR
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C12NMicroorganisms or enzymes20%
C07KPeptides14%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
Y02ATechnologies for adaptation to climate change3%
A61QSpecific use of cosmetics or similar toiletry preparations2%
A61LMethods or apparatus for sterilising materials or objects in general1%
B82YSpecific uses or applications of nanostructures1%
C03CChemical composition of glasses, glazes or vitreous enamels1%
PatentTitleYear
10,765,723Use of low dose IL-2 for treating autoimmune--related or inflammatory disorders202010,376,564Interleukin-2 for treating food allergy201910,293,028Use of low dose IL-2 for treating autoimmune related or inflammatory disorders20199,801,927'Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof'20179,765,304'Synthetic viruses and uses thereof'20179,757,471'Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery'20179,669,071'Method for stimulating T lymphocytes with IL-2'20179,457,096'Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery'20168,673,612'Synthetic viruses and uses thereof'20148,394,777'Treating immunodeficiencies by intrathymic injection of nucleotide sequences'20137,504,483'α-β C4BP-type recombinant heteromultimeric proteins'20097,074,411'α-β C4BP-type recombinant heteromultimeric proteins'20066,872,528'Highly productive packaging lines'20056,489,142'Methods and compositions for producing viral particles'20026,485,965'Replicating or semi-replicating viral constructs, preparation and uses for gene delivery'20026,383,807'Method of transforming T lymphocytes'20026,365,405'Compositions of chondrocytes, preparation and utilization'20026,333,171'CD4 gene regulatory sequences specifically expressed in mature T cells'20016,165,470'Albumin derivatives with therapeutic functions'20006,140,114'Defective viral vaccine particles obtained in vivo or ex vivo'20006,090,378'Composition comprising interleukin-2 and thymidine kinase for the treatment of tumors'20006,048,525'Cells designed as traps and their use as medicines'20006,004,803'Genes encoding HSV1-TK containing a deletion of 5\' cryptic promoter sites, vectors and cell lines'19995,948,675'Host-vector system which can be used in gene therapy'19995,843,432'Retroviral vectors for the treatment of tumors, and cell lines containing them'19985,514,542'Methods for propagating retrovirus for use in antibody assays'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2020Based in Paris, FR· patent location history
1998–2013Patents assigned to UNIV PARIS CURIE (12)· patent assignee history
2000–2020Patents assigned to INST NAT SANTE RECH MED (3)· patent assignee history
2013–2017Patents assigned to KLATZMANN DAVID (4)· patent assignee history
2016–2017Patents assigned to CONSEJO NAC DE INVESTIG CIENTIFICAS Y TECN (CONICET) (3)· patent assignee history
2017–2020Patents assigned to ASSIST PUBLIQUE—HOPITAUX DE PARIS (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV PARIS CURIE | 12 | 1998–2013 |
| ASSIST PUBLIQUE—HOPITAUX DE PARIS | 4 | 2017–2020 |
| KLATZMANN DAVIDself | 4 | 2013–2017 |
| CONSEJO NAC DE INVESTIG CIENTIFICAS Y TECN (CONICET) | 3 | 2016–2017 |
| INST NAT SANTE RECH MED | 3 | 2000–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Paris, FR | 26 | 1996–2020 |